 CHARLOTTESVILLE, VA ACCESSWIRE June 10, 2020 Adial Pharmaceuticals, Inc. NASDAQ:ADIL; ADILW Adial, a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, today announced that it has received an initial firm order for the purchase of 1,000 Rapid Result COVID-19 antibody test kits. The customer intends to utilize the test kits for understanding exposure to the virus in the City of Phoenix, Arizona and surrounding communities and to advance efforts to protect the health and safety of frontline workers. 